trials

The Food and Drug Administration on Friday granted a quick review of three experimental psychedelic drugs meant to treat major depression and post-traumatic stress disorder. It’s the latest move by the Trump administration signaling a shift in policy toward treatments that also give users a high — coming a day after the Justice Department said … Read more